000 01137 a2200289 4500
005 20250517010430.0
264 0 _c20150420
008 201504s 0 0 eng d
022 _a1541-0048
024 7 _a10.2105/AJPH.2014.302439
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJacobsen, Frederick M
245 0 0 _aSecond-generation antipsychotics and tardive syndromes in affective illness: a public health problem with neuropsychiatric consequences.
_h[electronic resource]
260 _bAmerican journal of public health
_cFeb 2015
300 _ae10-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aCentral Nervous System
_xdrug effects
650 0 4 _aDrug Labeling
650 0 4 _aHumans
650 0 4 _aMood Disorders
_xdrug therapy
650 0 4 _aMovement Disorders
_xetiology
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
773 0 _tAmerican journal of public health
_gvol. 105
_gno. 2
_gp. e10-6
856 4 0 _uhttps://doi.org/10.2105/AJPH.2014.302439
_zAvailable from publisher's website
999 _c24470496
_d24470496